Literature DB >> 7556541

Cultured rat microglia express C1q and receptor for C1q: implications for amyloid effects on microglia.

A R Korotzer1, J Watt, D Cribbs, A J Tenner, D Burdick, C Glabe, C W Cotman.   

Abstract

Senile plaques, the pathological hallmark of Alzheimer's disease (AD), are associated with complement components, including C1q. Reactive microglia appear to be involved in the later stages of plaque development. Since tissue macrophages are known to synthesize C1q, cultured rat microglia were examined for C1q immunoreactivity. Anti-C1q staining was detected, particularly in process-bearing microglia, indicating constitutive expression of C1q. Thus, microglia could provide a source of C1q for plaques even before becoming reactive. Since it has been previously shown that C1q binds beta 1-42, the major constituent of senile plaques, and since beta 1-42 is toxic to microglia in vitro, we asked if preincubation of beta 1-42 with C1q alters either metabolic indices of amyloid-induced degeneration in microglial cultures or the formation of amyloid deposits on these cells. While electron microscopic analysis of negatively stained amyloid fibrils confirmed that pre-incubation with C1q induced the association of C1q with the fibrils, no effect of the binding of C1q to beta 1-42 on beta 1-42 toxicity in microglia was observed. Interestingly, immunoreactivity for the C1q receptor that is known to modulate phagocytosis was found and was up-regulated in non-process-bearing microglia by interferon-gamma. While these data exclude a role for the C1q receptor in beta 1-42 toxicity in microglia, the observed expression and up-regulation of C1q receptor on microglia by interferon-gamma would be consistent with a role for C1q in complement-mediated inflammatory responses in AD and as a potential activator of microglial function in plaques.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556541     DOI: 10.1006/exnr.1995.1051

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Do nonsteroidal anti-inflammatory drugs have a protective effect against dementia?

Authors:  F L Van Muiswinkel; P Eikelenboom
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 2.  Microglia activation and anti-inflammatory regulation in Alzheimer's disease.

Authors:  Lih-Fen Lue; Yu-Min Kuo; Thomas Beach; Douglas G Walker
Journal:  Mol Neurobiol       Date:  2010-03-03       Impact factor: 5.590

3.  Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.

Authors:  Benoit Melchior; Angie E Garcia; Bor-Kai Hsiung; Katherine M Lo; Jonathan M Doose; J Cameron Thrash; Anna K Stalder; Matthias Staufenbiel; Harald Neumann; Monica J Carson
Journal:  ASN Neuro       Date:  2010-07-12       Impact factor: 4.146

4.  Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.

Authors:  Lalida Rojanathammanee; Angela M Floden; Gunjan D Manocha; Colin K Combs
Journal:  J Neuroinflammation       Date:  2015-03-04       Impact factor: 8.322

Review 5.  Diversity and Versatility of Phagocytosis: Roles in Innate Immunity, Tissue Remodeling, and Homeostasis.

Authors:  Justin J Lim; Sergio Grinstein; Ziv Roth
Journal:  Front Cell Infect Microbiol       Date:  2017-05-23       Impact factor: 5.293

6.  Amyloid Fibril-Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses.

Authors:  Jiang Wu; Bihua Bie; Joseph F Foss; Mohamed Naguib
Journal:  Mol Neurobiol       Date:  2020-02-01       Impact factor: 5.590

7.  Towards a transcriptome definition of microglial cells.

Authors:  L B Moran; D C Duke; F E Turkheimer; R B Banati; M B Graeber
Journal:  Neurogenetics       Date:  2004-03-20       Impact factor: 2.660

Review 8.  Innate immunity and neuroinflammation.

Authors:  Abhishek Shastri; Domenico Marco Bonifati; Uday Kishore
Journal:  Mediators Inflamm       Date:  2013-06-15       Impact factor: 4.711

9.  Increased complement C1q level marks active disease in human tuberculosis.

Authors:  Yi Cai; Qianting Yang; Yueqiang Tang; Mingxia Zhang; Haiying Liu; Guoliang Zhang; Qunyi Deng; Jian Huang; Zhiliang Gao; Boping Zhou; Carl G Feng; Xinchun Chen
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

10.  Microglia, Alzheimer's disease, and complement.

Authors:  Helen Crehan; John Hardy; Jennifer Pocock
Journal:  Int J Alzheimers Dis       Date:  2012-08-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.